> Skip repeated content

Corbus Offers Update of Scleroderma Therapy Anabasum at Ongoing ACR Meeting

Scleroderma News—November 6, 2017

Scleroderma News reported on a recent study co-authored by HSS rheumatologist Robert F. Spiera, MD, stating that a cannabinoid-derived drug could resolve skin inflammation in those with diffuse cutaneous scleroderma.

The study was presented at the American College of Rheumatology (ACR) Annual Meeting, and showed that the treatment normalized activity in genes related to inflammation.

Read the full article at sclerodermanews.com

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts